A r t i c l e s TUBB2B, TUBB3 and TUBB5 (also called TUBB). These tubulinrelated cortical dysgeneses are thought to involve a combination of abnormal neuronal proliferation, migration, differentiation and axonal guidance [8] [9] [10] . The vanishing boundaries between disorders of neuronal migration, cortical organization and proliferation have been highlighted by the recent identification of mutations in WDR62 and their implication in a large spectrum of malformations, including pachygyria, lissencephaly, polymicrogyria, schizencephaly, and hippocampal and cerebellar abnormalities 11, 12 . These findings, together with genetic and functional data, support the hypothesis that MCD-related genes are involved at multiple developmental stages and that proliferation and migration are genetically and functionally interdependent.
Sporadic, unexplained cases of MCD are by far the most common instances of these disorders, and identification of causative mutations remains a challenging task, in part because many result from de novo mutations (reviewed in ref. 13 ). To extend the spectrum of genes identified as being involved in MCD, we used a whole-exome sequencing (WES) approach and focused on variants in candidate genes encoding centrosomal and microtubule-related proteins.
RESULTS

Subgroups of individuals with MCD analyzed by WES
We selected 16 individuals with either lissencephaly or pachygyria (6 cases) or polymicrogyria (10 cases) associated with one of the following features: microcephaly (head circumferences more than 2-3 s.d. below the mean for age), dysgenesis of the cerebellum, brainstem or basal ganglia, or agenesis or dysgenesis of the corpus callosum (Supplementary Table 1 ). Supplementary Figure 1 highlights the overall experimental workflow for detecting and prioritizing sequence variants and validation of the MCD-related genes detailed below. All families had a single affected member (sporadic cases), except one family, in which MCD was diagnosed in four individuals (family P20; Fig. 1a) . For all subjects, mutations in known MCD genes (PAFAH1B1, DCX, TUBA1A, TUBB2B, TUBB3 and GPR56) and pathogenic copy-number variations had been previously excluded.
We applied WES methodology and, in line with previous studies 14, 15 , identified approximately 21,500 variants affecting essential splicing sites and coding regions in each subject. After applying variant filtering using available genomic databases (dbSNP, 1000 Genomes, Exome Variant Server and a local Paris Descartes Bioinformatics platform database) and excluding all variants with a frequency greater than 1%, we identified an average of 390 variants per subject (Supplementary Table 2) .
A germline mosaic KIF5C mutation
At first glance, in family P20 (Fig. 1a) , which includes four affected boys with severe MCD and microcephaly, the apparent transmission of the recurrent phenotype through the mother suggested the segregation of an X-linked disorder in this family. However, we found no linkage between the disease and a large set of X-linked markers ( Supplementary Fig. 2a,b) . Exclusion of the X chromosome and the unlikely possibility of autosomal-recessive inheritance (because of its occurrence even when the progenitor father was different) led us to consider a mosaic germline mutation in the mother. We therefore performed WES (using DNA from patient III-1; Fig. 1a ) and genome-wide SNP genotyping using a high-density microarray (Online Methods) Top, an analysis of sedimented microtubules by SDS-PAGE (as loading controls); bottom, autoradiographs of the same gels. Note that the p.Glu237Val alteration does not appreciably affect the ability of the protein to bind to microtubules. Fold KIF indicates the relative concentration of added KIF protein in the assay, where 1 refers to a molar ratio of 1:1,000 of KIF5 with respect to tubulin. (e) Kinetics of microtubule-dependent ATP hydrolysis by wild-type and mutant KIF5C proteins. The production of inorganic phosphate was measured kinetically in reactions containing taxol-stabilized microtubules, an equal amount of purified recombinant KIF5C protein and ATP using the malachite green colorimetric reaction. Diamonds and crosses represent wild-type and mutant (p.Glu237Val) proteins, respectively. Each time point represents the average of six experiments ± s.d. Note the complete absence of detectable ATP hydrolysis for the p.Glu237Val mutant protein. A 630 , absorbance at 630 nm. (f) Subcellular localization of transfected wild-type and p.Glu237Val mutant KIF5C in COS-7 cells. KIF5C immunostaining (green) shows a diffuse cytoplasmic distribution of wild-type KIF5C with enrichment, visualized as fluorescent puncta, along microtubules and in cortical regions of the cell, whereas mutant KIF5C heavily colocalizes with and decorates microtubules (identified by α-tubulin labeling, shown in red) throughout the cell but does not appear as puncta or accumulate in cortical clusters. DAPI was used as a counterstain to highlight nuclei. Scale bar, 20 µm.
of the affected family members and their mother to identify shared segments transmitted by the mother (Supplementary Table 3) . Among the shared genomic regions, we found a 44-Mb region on chromosome 2 ( Supplementary Fig. 2c,d ) harboring a missense variant (c.710A>T, p.Glu237Val) in KIF5C, encoding kinesin 5C ( Table 1) . We tested the segregation of this variant in the family and found it to be present in all affected individuals but absent from the mother's DNA (derived from blood) and the healthy son ( Supplementary Fig. 2d,e) . Also, in the case of the fetus corresponding to the most recent medical abortion of the mother's pregnancy, we tested expression of KIF5C alleles by RT-PCR using total RNA extracted from brain and lung and found that both alleles were expressed to the same extent (Supplementary Fig. 3a) . Taken together these data are consistent with a KIF5C germline mosaic mutation as the probable cause of the disease phenotype in the P20 family.
KIF5C encodes a member of the kinesin superfamily of proteins, most of which are ATP-dependent molecular motors involved in intracellular transport along microtubules 16 . The p.Glu237Val variant is located in the microtubule-interacting domain (Fig. 1b) , and three-dimensional modeling shows the surface location of this residue within the motor domain (Fig. 1c) . The p.Glu237Val alteration might be expected to affect conformational changes of the switch II loop, which is required for microtubule-dependent activation of the motor 16 .
To assess the consequences of the mutation on KIF5C function, we expressed and purified the motor domains of both wildtype and mutant KIF5C as recombinant proteins in Escherichia coli (Supplementary Fig. 3b ). The mutant protein behaved as a native species in gel filtration ( Supplementary Fig. 3c ), eliminating the possibility that the mutation might result in a completely misfolded or aggregated protein. We first compared the abilities of the wild-type and mutant proteins to bind to microtubules and found no marked difference (Fig. 1d) . However, when we measured the ability of each protein to hydrolyze ATP in a microtubule-dependent assay, we found a complete absence of measurable hydrolysis for the mutant protein (Fig. 1e) . This finding is consistent with the location of the altered residue in the crystal structure, as well as with the deleterious effect of the mutation in the severe MCD diagnosed in the P20 family (Supplementary Fig. 3d) .
To test the in vivo consequences of the p.Glu237Val alteration, we expressed wild-type and mutant KIF5C proteins by transfection in COS-7 cells and compared their distribution and localization by double-label immunofluorescence. As previously reported 17 , we found a diffuse cytoplasmic distribution of wild-type KIF5C with an enrichment, visualized as fluorescent puncta, along microtubules and in cortical regions of the cell ( Fig. 1f and Supplementary Fig. 3e ). In contrast, we found that mutant KIF5C heavily colocalizes with and decorates microtubules throughout the cell but does not appear as puncta or accumulate in cortical clusters ( Fig. 1f and Supplementary  Fig. 3e ). This result is consistent with the loss of ATPase activity shown by the in vitro assay and is also in agreement with earlier work on a nonmotile mutant Kif5c (p.Thr93Asn) that binds to microtubules but inhibits ATP hydrolysis 18 . For the mutation identified in this family, both KIF5C alleles are expressed. In common with most kinesins, KIF5C functions as a tetramer consisting of two heavy chains and two light chains. It is therefore possible that mutant KIF5C could titrate out the wild-type isoform and exert a dominant-negative effect.
Mutations in KIF2A
The identification of a mutation in KIF5C prompted us to screen this gene in a cohort of 162 individuals affected by various MCDs (Online Methods) and analyze all other variants in kinesin genes identified by WES and not reported in existing databases. Among 15 heterozygous variants, we found a single de novo missense change in KIF2A (c.961C>G, p.His321Asp) in a female subject (P462; Table 1 ) with frontal band heterotopia and posterior predominant pachygyria, severe congenital microcephaly and neonatal onset seizures (Fig. 2a,b , Table 1 and Supplementary Tables 1 and 4) . We then screened KIF2A (coding exons and their flanking sequences) in the same follow-up cohort and identified a second de novo missense variant in KIF2A (c.950G>A, p.Ser317Asn) ( Table 1 and Fig. 2a,b ) in a girl affected by congenital microcephaly and posterior predominant pachygyria (P147; Fig. 2a and Supplementary Table 4) .
KIF2A is a member of the M-kinesins (kinesin-13 family), in which the motor domain is located in the middle of the protein (Fig. 2b) . Rather than a direct involvement in microtubule-based motility, KIF2A functions by driving the ATP-dependent depolymerization of microtubules 19 . In addition to a potential deleterious effect predicted by the PolyPhen-2 and SIFT algorithms 20, 21 (Supplementary Table 5 ), inspection of the protein structure (Protein Data Bank (PDB) 2GRY; Fig. 2c) showed that both conserved residues Ser317 and His321 are located around the nucleotide binding pocket, suggesting that the ability of KIF2A mutants to bind and/or hydrolyze ATP is probably impaired. To investigate this possibility, we expressed the wild-type and mutant ATP-binding domains (residues 126-526) in E. coli as recombinant C-terminally hexahistidine (His 6 )-tagged proteins. We found that the wild-type protein was present as a conspicuous Coomassie-stained band in soluble extracts of host cells (Fig. 2d) . However, the two mutant proteins expressed in parallel soluble extracts were not convincingly identifiable; indeed, after affinity purification the mutant KIF2A proteins were recovered at substantially reduced amounts compared to the wild-type control protein and were present instead in higher amounts (relative to the wild-type control) in the insoluble fraction after host-cell lysis (Fig. 2d) . These data imply that the mutations lead to substantially reduced solubility as a result of misfolding and therefore result at a minimum in a reduced yield of functional protein. We also transfected constructs engineered for the expression of these KIF2A mutations into COS-7 and human fibroblast cells and analyzed them by immunofluorescence. We consistently found that both overexpressed mutant KIF2A proteins (p.His321Asp and p.Ser317Asn) had abnormal cellular localization ( Fig. 2e and  Supplementary Fig. 4a) . We also examined endogenous mutant 
KIF2A in fibroblasts derived from the subject bearing the c.961C>G (p.His321Asp) mutation and found similar results (Fig. 2f) .
In view of the fact that both KIF2A alleles are expressed in patient fibroblasts ( Supplementary Fig. 4b ) and the KIF2A molecule functions as a dimer 22 , our in vitro and in vivo data are consistent with a dominant-negative effect of these mutations.
Recurrent mutations in DYNC1H1 and TUBG1
We searched for the recurrence of mutations in the same gene in unrelated subjects with similar phenotypes and identified two variants in DYNC1H1 (P122 and P398; Table 4 ). The de novo mutations in DYNC1H1 were present in subjects with complex MCD from group A, whereas those in TUBG1 occurred in two subjects with MCD from group B (Supplementary Table 1 ). Because of the large spectrum of MCDs associated with mutations in genes such as WDR62, TUBA1A and TUBB2B 11,12,23 , we analyzed all variants detected in DYNC1H1 or TUBG1 in either group and identified (and confirmed) one additional de novo variant in DYNC1H1 in a subject from group B (P217; Table 1 and Fig. 3a) . To confirm the involvement of DYNC1H1 and TUBG1 in complex MCD, we screened coding exons in TUBG1 and DYNC1H1 in the cohort of 162 subjects with MCD. Consistent with our exome sequencing findings, we identified six additional DYNC1H1 mutations ( Table 1 and Supplementary Table 5 ). The discovery of the same mutation (encoding p.Arg3344Gln) in two unrelated subjects with a similar phenotype strongly supports the involvement of DYNC1H1 in MCD. For TUBG1, the screening identified one additional mutation (P478; Table 1 and Fig. 4a) . Whenever it was possible, an analysis of parental DNAs demonstrated the de novo occurrence of these mutations, with the exception of the DYNC1H1 variant encoding p.Lys3241Thr, which we identified as being associated with a familial form of MCD ( Table 1 and Supplementary Fig. 5 ). Consistent with a pathogenic effect, interspecies sequence comparison and prediction showed a high degree of conservation and potential deleterious effects of all residues involved (Supplementary Table 5 ). (e,f) Immunofluorescence staining of KIF2A (green) and α-tubulin (red) in either COS-7 cells transfected with wild-type or mutant (p.Ser317Asn and p.His321Asp) KIF2A cDNA constructs (e) or wild-type and p.His321Asp patient-derived fibroblasts (f). Note that instead of the expected diffuse punctiform cytoplasmic and nuclear distribution (as observed for wild-type KIF2A), KIF2A mutants showed a predominant colocalization with and decoration of microtubules. In cells expressing high levels of mutant forms of KIF2A, the decorated microtubule network is located mainly in the central region of the cells and around the nucleus with a disorganized and bundled appearance of microtubules. The nuclear distribution is also disrupted, and in both mutants, the nucleus is free of KIF2A. A similar altered distribution of KIF2A is evident in patient-derived fibroblasts. Scale bars (e,f), 20 µm. 24, 25 , we re-evaluated our patients and found clear clinical evidence of peripheral neuropathy in three cases. We further confirmed this in one subject by nerve conduction studies. The DYNC1H1 (cytoplasmic dynein 1 heavy chain 1) protein is a large (>530 kDa) crucial subunit of the cytoplasmic dynein complex 26, 27 . The C-terminal region (residues 1846-4646) is the motor domain complex; it is arranged as a heptameric ring with seven AAA domains and a stalk from which protrudes a microtubule-binding domain 26 . Notably, six out of the eight mutations we identified in individuals with MCD are located either in the stalk domain, in AAA1 or in the linker region; the remaining two are in the tail domain (Fig. 3a) .
One of these latter mutations is located outside of the homodimerization domain, whereas the second (leading to a deletion of four residues) is located in a region that is required for binding of the associated light chains DYNC1L and DYNC1LI (Fig. 3a) . Homology modeling of the DYNC1H1 alterations showed that three are located on the surface of the microtubule binding domain (Fig. 3c) . Previous in vitro experiments have shown that a nearby alteration (p.Arg3384Pro) weakens microtubule binding 26 (the residue is referenced as R3382 in the previous work).
We evaluated the effect of two of our newly discovered DYNC1H1 mutations on microtubule binding. Wild-type and mutant (p.Lys3336Asn and p.Arg3384Gln) sequences containing the DYNC1H1 microtubule binding domain were fused with the antiparallel coiled-coil side arm contained in the native structure of seryl-transfer RNA (tRNA) synthetase 27 as C-terminally His 6 -tagged proteins. This chimeric arrangement fixes the alignment of the two strands of the coiled-coil arm in their native conformation such that their registry results in a relatively high microtubule binding affinity 26 were tested for their ability to co-sediment through sucrose cushions either in the presence (+Tub) or absence (−Tub) of taxol-polymerized microtubules. Labeled material (DYN, seryl-tRNA synthetase-DYNC1H1 MTBD fusion proteins) contained in the supernatants (S) and pellets (P) was analyzed by SDS-PAGE. Note that for the mutant proteins, the amount of label sedimenting with microtubules was reduced to a level close to that present in control reactions done without added tubulin.
A r t i c l e s recombinant proteins in E. coli, affinity purified them and tested their ability to co-sediment with taxol-polymerized microtubules through sucrose cushions. This experiment showed a substantial reduction in the microtubule binding affinity of both the p.Lys3336Asn and p.Arg3384Gln mutants compared to the wild-type control protein (Fig. 3d) .
Functional effects of TUBG1 mutations
Two subjects with TUBG1 mutations (P367, c.1160T>C, p.Leu387Pro; and P388, c.275A>G, p.Tyr92Cys) share a complex MCD combining posteriorly predominant pachygyria (or agyria) and severe microcephaly (−4 s.d.). The third but less severe case (P478, c.991A>C, p.Thr331Pro) showed posterior pachygyria and laminar heterotopia with a thick and dysmorphic corpus callosum (Fig. 4b and  Supplementary Table 4) . TUBG1 is one of two human genes encoding γ-tubulin 28 and is highly expressed in fetal brain. The protein is a structural component of the centrosome and associates with at least six other proteins to form the γ-tubulin ring complex (γTuRC), which functions in microtubule nucleation 29 . Two of the altered residues (Thr331 and Leu387) are located in buried sites in two distinct α-helices (Fig. 4c) ; their alteration to proline residues is likely to destabilize these helices. One of these residues (Thr331) is located in the γ-γ interaction domain; the conserved altered residue (Tyr92) is located in the vicinity of the GTP binding site (Fig. 4c) .
The events leading to the assembly of the γTuRC are unknown. However, γ-tubulin, similarly to the components of the α/β-tubulin heterodimer, requires facilitated folding by the cytosolic chaperonin CCT and is discharged from it as a monomer 30 . We therefore assessed the effect of two of the γ-tubulin alterations (p.Tyr92Cys and p.Leu387Pro) on facilitated folding and on the structural stability of the monomer in vitro. The latter experiment showed that the integrity of the recombinant proteins is not affected by either of the diseaseassociated mutations (Supplementary Fig. 6 ). Conversely, we found a diminished yield of material migrating as monomeric γ-tubulin for p.Leu387Pro with a corresponding increase (relative to the wild-type protein) of radioactivity migrating as an undischarged binary complex with CCT (Fig. 4d) . These data suggest that the chaperonin-dependent folding (and hence the yield) of monomeric γ-tubulin is compromised by the p.Leu387Pro alteration. The effect of the p.Tyr92Cys alteration on facilitated folding through interaction with chaperonin is less evident (Fig. 4d) , and it therefore seems probable that this alteration (and perhaps the others, to some extent) exerts its influence through the assembly and/or functional integrity of the γTuRC.
We analyzed the consequences of these newly discovered γ-tubulin alterations in vivo in two ways. First we investigated the phenotype in yeast (S. cerevisiae) cells in which we introduced these alterations into the conserved (although nonidentical) residues in the single yeast γ-tubulin gene TUB4 (Supplementary Fig. 7a) . All of the mutant heterozygous and homozygous strains we generated were viable. However, although we found no change in microtubule plus-end dynamics (Supplementary Table 6 ), cells harboring TUB4 p.Trp92Cys showed an enhancement in the number and average maximal length of astral microtubules, as well as a decrease in the frequency of nucleation of new microtubules from the spindle pole body (Supplementary Table 7 and Supplementary Fig. 7b) . Moreover, we found abnormal mitotic features in a large number of cells (TUB4 p.Trp92Cys, 23%; TUB4 p.Val387Pro, 8%), consistent with incorrect nuclear positioning and reflecting a defect in mitotic microtubule organization (Fig. 5a and Supplementary Table 7) . These data are consistent with both the disease-causing γ-tubulin alterations having a deleterious effect on crucial aspects of microtubule behavior and with the more severe clinical phenotype associated with the p.Tyr92Cys alteration. Second, we used in utero RNA interference (RNAi) to analyze the consequences of Tubg1 downregulation on cortical radial neuronal migration in mice. We found that brain sections of embryonic day (E) 18.5 embryos that had been electroporated 4 d previously with short hairpin RNA (b) Brain MRI scans of subjects with TUBG1 mutations. First row, axial T1-weighted images in three different patients (P388, first column; P478, second column; and P367, third column) with different TUBG1 mutations showing different degrees of pachygyria, with a thick cortex that is most prominent in the parietooccipital regions of patients P388 and P367 (white asterisks). In the less severe case, patient P478, the pachygyria is milder, with an aspect of posterior subcortical band heterotopia (red asterisks). Second row, sagittal T1-weighted sections showing a dysmorphic thick corpus callosum. Note that in the three cases, the cerebellum and brainstems are normal. (c) Three-dimensional model of the TUBG1 dimer (PDB 3CB2) showing the localization of the three altered residues and the bound GTP molecule (yellow). (d) Effect of γ-tubulin alterations on facilitated folding. Sequences encoding full-length wild-type and mutant (p.Tyr92Cys, p.Leu387Pro) γ-tubulin were expressed as 35 S-labeled proteins in reticulocyte lysate, and the reaction products were analyzed by gel filtration on Superose 6. Fractions emerging from the column were subjected to SDS-PAGE, and the radioactivity migrating as γ-tubulin was quantified using a phosphorimager. Note the diminished yield of material migrating as monomeric γ-tubulin for p.Leu387Pro, with a corresponding increase (relative to the wild-type protein) of radioactivity migrating as a binary complex with the cytosolic chaperonin (the CCT binary complex has the same apparent mass as the largest molecular mass marker, thyroglobulin, indicated by the black arrowhead). Arrows mark the elution positions of molecular mass standards run under identical conditions: thyroglobulin (black), 670 kDa; IgG (orange), 158 kDa; ovalbumin (purple), 44 kDa; and myoglobin (red), 17 kDa.
(shRNA) targeting Tubg1 showed a significant fraction of red fluorescent protein (RFP)-positive cells in the subventricular and intermediate zone (P < 0.01), suggesting that Tubg1 downregulation induced a significant arrest of migrating cells (Fig. 5b,c) . In contrast, embryos transfected identically in utero with RFP alone showed strong labeling in the cortical plate (P < 0.001; Fig. 5b,c) . Expression of scrambled shRNA controls had no effect on migration, whereas shRNA-induced neuronal migration defects were substantially rescued by overexpression of a wild-type human TUBG1 complementary DNA (cDNA) (Fig. 5b,c) . Quantification of these effects is shown in Figure 5c . We repeated these in utero RNAi experiments using a second shRNA targeting the coding sequence and found that it also affected neuronal radial migration, although the positions of misplaced cells were more dispersed than with the first shRNA (data not shown). This observation is probably attributable to the fact that downregulation of Tubg1 expression using the first shRNA was more efficient than when the second shRNA was used (data not shown). We conclude that TUBG1 has a crucial role in neuronal migration during corticogenesis.
DISCUSSION
Among 16 subjects analyzed by WES, we identified mutations in four genes (KIF5C, KIF2A, DYNC1H1 and TUBG1) encoding proteins that interact with microtubules in 7 of 16 cases. The remaining nine subjects include four in whom all tested variants were inherited from one of the healthy parents and five with de novo events predicted to alter protein functions but with no clear link to microtubules (Supplementary Table 8) . Further screening and re-evaluation of MRI data showed that mutations in KIF5C, KIF2A, DYNC1H1 and TUBG1 are involved in a wide range of cortical and gyral pattern abnormalities associated with microcephaly, callosal, cerebellum and/or brainstem dysgenesis (Supplementary Table 4) . First, in the familial form of severe MCD described here (P20; Fig. 1 ), we obtained convincing evidence for the presence of a maternal mosaic germline mutation in KIF5C that is responsible for the phenotype in four male subjects. There is now a wide range of disorders for which the occurrence of parental germline mosaicism has been reported 31 . Indeed, with the recent application of DNA sequencing to whole genomes and whole exomes, the frequency of somatic and germline mosaicism may be higher than is currently appreciated. Our results highlight both the contribution of germline mosaic mutational events in families with recurrent genetic disorders and the power of WES to resolve these situations. For KIF5C, we note that a recent report documented a de novo mutation in a sporadic case with severe intellectual disability and microcephaly for whom MRI data were not available 32 . Second, subjects with mutations in KIF2A or TUBG1 share microcephaly and a cortical gyration pattern that more severely affects the posterior cortex. This gyration pattern is reminiscent of the PAFAH1B1-related cortical gyration pattern 33 . Third, mutations in DYNC1H1 are the cause of a wide spectrum of cortical malformations characterized mainly by posterior pachygyria (present in 8/11 individuals with DYNC1H1 mutations studied here; Supplementary Table 4) . Some individuals with mutations in DYNC1H1 had evidence of additional abnormalities, including microcephaly, nodular heterotopia, hypoplasia of the corpus callosum and dysmorphy of the basal ganglia, as well as evidence of peripheral neuropathy (3/11). However, the most striking finding is the concomitant presence in two individuals of both pachygyria and polymicrogyria patterns (P122 and P217; Fig. 3 and Supplementary Table 4) , which are traditionally regarded as distinct entities. This association has also been reported in WDR62-related disorders 11 that include individuals with microcephaly, polymicrogyria and schizencephaly.
Interestingly, missense mutations in DYNC1H1 have been associated primarily with neuropathy: an axonal dominant form Bars represent the mean ± s.e.m. of fluorescence intensities in ten equal strata (with stratum one corresponding to the VZ and stratum ten corresponding to the MZ) dividing the cortices of independent brains (tomato, n = 4; scramble, n = 3; shTubg1, n = 11; rescue, n = 2). Note that knockdown with shTubg1 leads to an increase in the percentage of transfected cells located in the SVZ and IZ (strata 3 and 4) and a significant decrease in the upper layers of the CP (strata 9 and 10) compared with the scramble control. Cells transfected with shTubg1 and pCMV6-Tubg1 mainly reached the upper layers of the CP (strata 8 to 10), showing that migration disruption is a specific consequence of Tubg1 RNAi. *P < 0.1, **P < 0.01, *** P < 0.001 calculated by Student's t test.
of Charcot-Marie-Tooth disease 25 and a dominant form of spinal muscular atrophy 24, 34 . More recently, de novo missense mutations in DYNC1H1 were reported in two individuals with intellectual disability and signs of cortical malformations 32, 35 . Taken together these data indicate that heterozygous missense mutations in DYNC1H1 underlie a broad phenotypic spectrum extending from peripheral neuropathies to cerebral malformations. However, DYNC1H1 is emerging as an important and principal locus for mutations responsible for MCD, and its screening should be recommended in unexplained and difficult-to-classify lissencephaly, pachygyria and polymicrogyria with or without microcephaly. The data reported here extend the association between microtubulebased cellular processes and proper cortical development 8, 9, 36, 37 to γ-tubulin and the microtubule-dependent motor proteins KIF5C, KIF2A and DYNC1H1. Regarding the α-and β-tubulin isotypes (TUBA1A, TUBB2B, TUBB3 and TUBB5), all mutations identified so far in the genes encoding these proteins are heterozygous missense mutations. In the absence of loss-of-function mutations (that is, nonsense, frameshift, splicing or genomic deletions), these observations are consistent with dominant-negative effects rather than haploinsufficiency as the primary molecular mechanism causing disease. This hypothesis is further supported by our data showing the behavior of mutant forms of KIF5C and KIF2A in cells. It is nonetheless possible that haploinsufficiency could also contribute to functional defects of MCD-related proteins.
Our phenotypic evaluation of S. cerevisiae strains harboring disease-causing alterations in TUB4 as well as our in utero suppression experiments suggest that adequate expression of TUBG1 is required for normal microtubule behavior and proper neuronal migration. Previous studies, including analyses of Kif2a -/-and Kif5c -/-mice 19, 38 , imply that sufficient expression of functional KIF5C, KIF2A and DYNC1H1 proteins is also required for proper cortical development. For DYNC1H1, inactivation of the mouse homolog is embryonic lethal 39 , whereas N-ethyl-N-nitrosourea (ENU)-induced mouse mutants harboring heterozygous missense mutations in the tail domain (Legs at odd angles (Loa, p.Phe580Tyr) and Cramping 1 (Cra1, p.Tyr1055Cys)) result mainly in early onset progressive neurodegenerative diseases 40 . This analysis also identified defects in retrograde axonal transport 40 and in hippocampal neocortical lamination and neuronal migration 41 . In line with these results, another study reported that in vivo RNAi-mediated downregulation of Dync1h1 impairs neuronal migration and positioning in the developing neocortex 42 .
Our data strongly suggest that the regulation of microtubuledependent mitotic processes in progenitor cells, as well as the trafficking activities of the microtubule-dependent molecular motors KIF2A, KIF5C and DYNC1H1 in postmitotic neuronal cells, are collectively essential for correct neuronal development (Supplementary Fig. 8 ).
In light of this conclusion, it is understandable that functional disruption of any of these genes can lead to substantial defects in neuronal polarization, migration and differentiation.
METHODS
Methods and any associated references are available in the online version of the paper.
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ONLINE METHODS
Subjects. Blood or DNA samples from affected individuals and their parents and informed consent were obtained from all participants according to local institutional review board guidelines. We selected 16 cases with either lissencephaly (6 cases) or polymicrogyria (10 cases) in association with at least one of the following features: microcephaly or dysgenesis of the cerebellum, brainstem, basal ganglia or corpus callosum. Subjects with lissencephaly included those with agyria, pachygyria or subcortical laminar heterotopia, and subjects with polymicrogyria included those with perisylvian, frontal, diffuse and multifocal polymicrogyria.
We used an additional cohort of 162 cases comprising 80 individuals with polymicrogyria, 58 with lissencephaly and 24 with predominant posterior pachygyria to perform extensive screening of candidate genes. These included 57 cases with microcephaly, 74 with dysgenesis or agenesis of the corpus callosum, 18 with dysmorphic basal ganglia and 38 with cerebellar vermian and/or hemispheric hypoplasia or dysplasia.
We analyzed all affected individuals' DNAs by comparative genomic hybridization (CGH) microarray using the NimbleGen chip 720,000-probes (720 K) array (Roche-NimbleGen) to exclude potential pathogenic copy-number variations. Metabolic screening was performed to exclude metabolic disorders. Likewise, we screened the coding regions of DCX, PAFAH1B1, ARX, TUBA1A, TUBB2B, TUBB3 and GPR56 to exclude pathogenic mutations [43] [44] [45] [46] .
Genotyping. We performed high-throughput microarray genotyping of approximately 262,000 SNPs using one array (version NspI) from the Affymetrix GeneChip Human Mapping 500K Array set (Affymetrix) following the recommended protocol as described in the Affymetrix manual.
WES and analysis. Library generation, exome enrichment and WES were performed at the French National Centre for Genotyping (CNG, Evry, France). Briefly, libraries were prepared from 3 µg genomic DNA extracted from whole blood using an optimized SureSelect Human Exome kit (Agilent) following the manufacturer's instructions. Captured, purified and clonally amplified libraries targeting the exome were then sequenced on a HiSeq 2000 (Illumina) according to the manufacturer's recommendations. Obtained sequence reads were aligned to the human genome (hg19) using BWA software 15 . Downstream processing was carried out with the Genome analysis toolkit (GATK) 47, 48 , SAMtools 49 and Picard Tools (http://picard.sourceforge.net/). Single-nucleotide variants and indels were subsequently called by the SAMtools suite (mpileup, bcftools, vcfutil). All calls with a read coverage ≤5× and a Phred-scaled SNP quality of ≤20 were filtered out. Substitution and variation calls were made with the SAMtools pipeline (mpileup). Variants were annotated with an in-house Paris Descartes bioinformatics platform pipeline based on the Ensembl database (release 67) 50 .
Variations validation and gene screening. After exome analysis, each selected variant was confirmed by PCR and direct sequencing using DNA from the patient and his or her parents. For each patient, the complete TUBG1 and KIF5C coding sequences and splice sites, as well as exons corresponding to the AAA1 and stalk domains of DYNC1H1, were amplified in independent PCR reactions from genomic DNA and sequenced using BigDye dideoxy terminator chemistry and an ABI3700 DNA analyzer (Applied Biosystems). Primer sequences and positions, PCR conditions and product sizes are available upon request.
Protein modeling. Amino acid substitutions were plotted on the solved protein structures for rat kinesin, the human KIF2A nucleotide binding domain, human TUBG1 and the mouse Dync1h1 stalk domain in fusion with seryltRNA synthetase from T. thermophilus using PyMOL software (http://www. pymol.org/). Models were built by homology modeling using Research Collaboratory for Structural Bioinformatics PDB codes 3KIN, 2GRY, 3CB2 and 3ERR. Images in Figures 1-4 were rendered using PyMOL.
Cloning, expression and in vitro translation. A plasmid containing the fulllength sequence of KIF5C was provided by Professor F.A. Stephenson (School of Pharmacy, University of London). A sequence encoding the N-terminal 380 residues of KIF5C containing a C-terminal His 6 tag was generated from this clone by PCR. Sequences encoding full-length human γ-tubulin were from B.R. Oakley 30 . A sequence encoding the DYNC1H1 microtubule binding domain was obtained by PCR using a human brain cDNA library (Clontech) as a template and inserted into the seryl-tRNA synthetase 12 heptadcontaining α-registry fusion construct described by Carter et al. 26 (GenBank FJ039866). Mutations were introduced by site-directed mutagenesis using the QuikChange II kit (Stratagene). For experiments requiring in vitro expression, sequences were inserted into the pET23b vector (Novagen, EMD Millipore Germany) and used to drive expression in either rabbit reticulocyte lysate (TNT, Promega) containing 35 S-methionine or in E. coli BL21DE3 pLysS, in which synthesis of endogenous E. coli proteins was suppressed by incubation in the presence of rifampicin 51 . In bacterial expression experiments, lysis was effected 2 h after induction with isopropyl β-d-1-thiogalactopyranoside (IPTG) by two successive cycles of freezing and thawing followed by incubation with DNAse I and centrifugation as previously described 52 . Affinity purification of His 6 -tagged proteins from the resulting supernatants was done with solid phase-bound Co 2+ beads using the protocol recommended by the manufacturer (Clontech). The purity of the expressed proteins was checked by SDS-PAGE. In some experiments, the integrity of in vitro-translated wild-type and mutant forms of γ-tubulin was assessed by measuring its susceptibility to digestion with proteinase K as described 53 .
Gel filtration analyses. The migration properties of the recombinant wildtype and mutant forms of KIF5C sequences containing the motor domains and a portion of the stalk domain were assessed on a column (1.0 cm × 30 cm) of Superose 6 using fast protein liquid chromatography (FPLC) (GE) run in 20 mM sodium phosphate buffer, pH 7.2, containing 0.1 M NaCl, 0.5 mM ethylene glycol tetraacetic acid (EGTA) and 1 mM dithiothreitol (DTT) (buffer K). The products of in vitro TNT reactions done in rabbit reticulocyte lysate (10 µl) were diluted with 0.1 ml of buffer K supplemented with 20 µM GTP and centrifuged for 15 min at 100,000g at 4 °C to remove all particulate material. The resulting supernatant was applied to the Superose 6 column equilibrated and run in buffer K containing 20 µM GTP and 5% (vol/vol) glycerol. Radioactivity contained in 0.5-ml fractions was measured in 20 µl aliquots by scintillation counting, and further aliquots were analyzed by SDS-PAGE and autoradiography. Radioactivity contained in the band corresponding to γ-tubulin was quantified using a phosphorimager.
Measurement of rates of ATP hydrolysis. ATP hydrolysis by recombinant wild-type and p.Glu237Val mutant forms of KIF5C was measured in 20-µl reactions containing 1.0 pmol of purified protein in 20 mM PIPES buffer, pH 6.9, 1.0 mM MgCl 2 , 0.5 mM ATP and 1.0 mg (measured as total protein) of taxol-polymerized microtubules. Reaction mixtures were incubated at 30 °C. At various intervals, aliquots (2.0 µl) were withdrawn, and the inorganic phosphate content was measured using the malachite green phosphomolybdate assay 54 .
Microtubule binding assays. Microtubules purified from bovine brain 55 were depolymerized in 20 mM PIPES buffer, pH 6.9, 1 mM MgCl 2 and 1 mM EGTA by incubation on ice and cleared by centrifugation at 60,000g for 10 min. Purified 35 S-labeled KIF5C (in the range 0.2-6.9 nmoles) or 35 S-labeled chimeric seryl-tRNA synthetase containing the DYNC1H1 microtubule binding domain was added to reactions (10 µl) containing 2.0 mg/ml depolymerized tubulin, 1 mM GTP, 0.5 mM AMP-PNP and 20 mM taxol, and the mixtures were incubated at 30 °C for 20 min. Reaction products were loaded onto cushions (0.25 ml) containing 1 M sucrose in 40 mM MES, pH 6.8, 0.5 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM GTP, 0.25 mM AMP-PNP and 10 mM taxol contained in 1.5 ml Eppendorf tubes and centrifuged for 15 min at 100,000g at 30 °C in a Beckman TL-100 rotor. The protein and radioactivity content of the resulting microtubule pellets (in the case of reactions done with bacterially expressed KIF5C proteins) or pellets and supernatants (in the case of experiments done with in vitro-translated KIF5C and dynein heavy chain fragments) was determined following SDS-PAGE.
Folding of KIF2A nucleotide binding domains. Sequences spanning the centrally located nucleotide binding domain of human KIF2A (residues 126-526) were obtained by PCR using full-length cloned wild-type (Origene)
